Investing NewsCytokinetics Stock Skyrockets on Positive Results from Study of Its Heart DrugDecember 27, 2023 by admin 0 Comments Cytokinetics Inc. reported positive results Wednesday from a key Phase 3 study of its experimental drug to treat heart disease. Articles You May Like Oracle Stock: Buy Now and Hold Tight for the AI and Healthcare Gold Rush First Berkshire Hathaway annual meeting without Charlie Munger: What to expect from Warren Buffett 3 Speculative Stocks That Could Make You a Fortune (if You Dare) Exxon Mobil reaches agreement with FTC, poised to close $60 billion Pioneer deal 3 Steady Stocks Predicted to Double in Value by 2026